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Abstract
Background: The SMXA-5 mouse is an animal model of high-fat diet-induced fatty liver. The major QTL for fatty
liver, Fl1sa on chromosome 12, was identified in a SM/J × SMXA-5 intercross. The SMXA-5 genome consists of the
SM/J and A/J genomes, and the A/J allele of Fl1sa is a fatty liver-susceptibility allele. The existence of the
responsible genes for fatty liver within Fl1sa was confirmed in A/J-12SM consomic mice. The aim of this study was
to identify candidate genes for Fl1sa, and to investigate whether the identified genes affect the lipid metabolism.
Results: A/J-12SM mice showed a significantly lower liver triglyceride content compared to A/J mice when fed the
high-fat diet for 7 weeks. We detected differences in the accumulation of liver lipids in response to the high-fat diet
between A/J and A/J-12SM consomic mice. To identify candidate genes for Fl1sa, we performed DNA microarray
analysis using the livers of A/J-12SM and A/J mice fed the high-fat diet. The mRNA levels of three genes (Iah1, Rrm2,
Prkd1) in the chromosomal region of Fl1sa were significantly different between the strains. Iah1 mRNA levels
in the liver, kidney, and lung were significantly higher in A/J-12SM mice than in A/J mice. The hepatic Iah1
mRNA level in A/J-12SM mice was 3.2-fold higher than that in A/J mice. To examine the effect of Iah1 on hepatic lipid
metabolism, we constructed a stable cell line expressing the mouse Iah1 protein in mouse hepatoma Hepa1-6 cells.
Overexpression of Iah1 in Hepa1-6 cells suppressed the mRNA levels of Cd36 and Dgat2, which play important roles in
triglyceride synthesis and lipid metabolism.
Conclusions: These results demonstrated that Fl1sa on the proximal region of chromosome 12 affected fatty liver in
mice on a high-fat diet. Iah1 (isoamyl acetate-hydrolyzing esterase 1 homolog) was identified as one of the candidate
genes for Fl1sa. This study revealed that the mouse Iah1 gene regulated the expression of genes related to lipid
metabolism in the liver.
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Background
Fatty liver is associated with dyslipidemia, type 2 dia-
betes mellitus, and obesity. The SMXA-5 mouse is an
animal model of high fat diet (HFD)-induced type 2 dia-
betes and fatty liver [1]. The SMXA-5 strain is an
SMXA-recombinant inbred (RI) strain established from
breeding between SM/J mice and A/J mice [2], and thus
the SMXA-5 genome is a mosaic genome derived from
SM/J mice and A/J mice. On a commercial chow diet,
SM/J mice and A/J mice did not show hyperglycemia
and impaired glucose tolerance (IGT), but SMXA-5
mice showed IGT [3]. On a high-carbohydrate diet, SM/
J mice and A/J mice were resistant to IGT and fatty liver
compared with SMXA-5 mice [1]. On the HFD, although
the traits were deteriorated in all strains, both parental
strains were without either diabetes or fatty liver. But
SMXA-5 mice developed type 2 diabetes and fatty liver on
the HFD. It was speculated that the parental strains pos-
sess the latent susceptibility loci for type 2 diabetes and
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fatty liver [1]. We previously performed a search of genetic
factors for fatty liver in SMXA-5 mice by quantitative trait
locus (QTL) analysis in (SM/J × SMXA-5)F2 intercross
mice [4]. We detected several QTLs for liver weight, liver
total lipids, liver total cholesterol (TC), and liver triglycer-
ides (TG) on mouse chromosomes 2, 6, 10, 11, 12, and 17.
On chromosome 12, a significant QTL for liver TG and
highly significant QTLs for relative liver weight/liver lipid
content were detected near D12Mit58 (17.1 Mb) and
D12Mit270 (32.3 Mb), respectively. Chromosome 12 of
SMXA-5 had the A/J-derived genome from the centro-
mere to 54.1 Mb, and the SM/J-derived genome from
54.1 Mb to the telomere. The major QTL for fatty liver on
chromosome 12 was designated Fl1sa (fatty liver 1 in the
SMXA RI strains). The A/J allele of Fl1sa (on centromere-
54.1 Mb) contributed to an increase in lipid accumulation
in the liver. The effect of Fl1sa was confirmed in A/J-12SM
chromosomal substitution (consomic) mice [4]. On the
HFD, A/J-12SM consomic mice that possessed the SM/J
allele of Fl1sa showed lower lipid accumulation in the
liver than A/J mice.
In this study, we first attempted to determine the time
period when the differences in liver TG accumulation
between A/J mice and A/J-12SM mice appeared. The
effect of the responsible gene(s) for Fl1sa that existed on
the A/J-derived region of chromosome 12 (centromere-
54.1 Mb) in SMXA-5 emerged after 7 weeks of feeding
with the HFD. Secondly, we tried to identify candidate
genes involved in the Fl1sa-regulated control of lipid ac-
cumulation in the liver by DNA microarray analysis. We
identified only three genes that had significantly different
expression levels in the liver between A/J-12SM and A/J
mice. The function of one of these candidate genes,
mammalian Iah1, had not been reported, although the
yeast IAH1 protein is known to show esterase activity
[5, 6]. Thirdly, to clarify the function of mouse Iah1,
we investigated lipid metabolism in the cells stably
overexpressing the mouse Iah1 gene.
Results
Phenotypic analyses of A/J-12SM consomic mice at 3, 7, or
11 weeks of feeding with the HFD (Fig. 1 and Table 1)
At 11 weeks of feeding with the normal diet (ND), the
body weights (A/J, 29.3 ± 0.6 g; A/J-12SM, 27.4 ± 0.9 g),
serum TG levels (A/J, 101 ± 8 mg/dl; A/J-12SM, 119 ±
7 mg/dl) and serum TC levels (A/J, 100 ± 3 mg/dl; A/J-
12SM, 106 ± 7 mg/dl) were similar between A/J mice and
A/J-12SM mice. Liver TG and liver total lipids in A/J-
12SM mice were significantly lower than those in A/J
mice at 11 weeks of feeding with the HFD (Fig. 1a and
b). These results were consistent with our previous study
[4]. However, there were no significant differences in
liver TG and liver total lipids between A/J mice and A/J-
12SM mice at 11 weeks of feeding with the ND (Fig. 1a
and b). The levels of liver total lipids in mice fed the ND
were markedly lower than those in mice fed the HFD.
These results indicate that Fl1sa, the locus for liver
lipids accumulation on chromosome 12, affected HFD-
induced fatty liver. Therefore, we attempted to deter-
mine the time period when the differences of liver TG
accumulation between A/J mice and A/J-12SM mice ap-
peared. Fl1sa was detected in (SM/J × SMXA-5)F2 inter-
cross mice at 7 weeks of feeding with the HFD [4]. In
this study, we analyzed the traits in A/J-12SM mice and
A/J mice at 3 or 7 weeks of feeding with the HFD. Feed-
ing with the HFD increased the content of liver TG and
liver total lipids compared to feeding with the ND
(Fig. 1a and b), but there were no differences between
A/J mice and A/J-12SM mice at 3 weeks of feeding with
the HFD. The levels of liver TG and liver total lipids in
A/J mice increased from 3 to 7 weeks of feeding, but not
in A/J-12SM mice. At 7 weeks of feeding, A/J-12SM mice
Fig. 1 Liver TG and total lipids of A/J mice and A/J-12SM consomic mice at 3, 7, or 11 weeks of feeding with the high-fat diet. a Liver TG and
(b) total lipids of A/J mice and A/J-12SM mice at 3, 7, or 11 weeks of feeding with the HFD. ND, 11 weeks of feeding with the ND (n = 8–10;
**P < 0.01 versus A/J mice under the same experimental conditions)
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had significantly lower contents of liver TG and of liver
total lipids than A/J mice. At 7 weeks of feeding with
the HFD, the body weight, body mass index, total food
intake, and the weights of each type of adipose tissues
(subcutaneous fat, epididymal fat, retroperitoneal fat,
and mesenteric fat) did not differ between A/J mice and
A/J-12SM mice (Table 1). The liver weight in A/J-12SM
mice was significantly lower than that in A/J mice. In
addition, the blood glucose and serum insulin concen-
trations in A/J-12SM mice were lower than those in A/J
mice (Table 1). Serum TG, serum HDL-C, and serum
free fatty acids (FFA) concentrations in A/J-12SM mice
were similar to those in A/J mice (Fig. 2a and b). How-
ever, the serum TC level in A/J-12SM mice was lower
than that in A/J mice (Fig. 2a).
Hepatic gene expression analyses between A/J and
A/J-12SM consomic mice (Table 2 and Fig. 3a)
Total RNA was extracted from the livers of A/J mice
or A/J-12SM consomic mice fed the HFD for 7 weeks.
We performed DNA microarray analysis using total
RNA from the liver and compared the levels of gene ex-
pression between A/J and A/J-12SM. On chromosome
12, we detected 20 genes differentially expressed be-
tween A/J mice and A/J-12SM mice (P < 0.01) (Table 2).
Five genes (Iah1, Ywhaq, Rrm2, Prkd1, and G2e3) exist
in the chromosomal region of Fl1sa (centromere-
54.1 Mb). Using a real-time RT-PCR (qPCR) method, we
confirmed that the gene expression levels of Iah1 (iso-
amyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae),
21.3 Mb), Rrm2 (ribonucleotide reductase M2 subunit,
24.7 Mb), and Prkd1 (protein kinase D1, 50.3 Mb) were
significantly different between A/J mice and A/J-12SM
mice (Fig. 3a). However, the Ywhaq and G2e3 mRNA
levels in A/J-12SM mice did not differ from those in A/J
mice. The hepatic Iah1 mRNA level in A/J-12SM mice
was 3.2-fold higher than that in A/J mice. In contrast,
the hepatic Rrm2 mRNA level in A/J-12SM mice (0.30
± 0.03) was significantly lower than that in A/J mice
(1.00 ± 0.10). The Prkd1 mRNA level in A/J-12SM mice
(0.64 ± 0.05) was also significantly lower than that in
A/J mice (1.00 ± 0.08).
Tissue distributions of mouse Iah1 expression (Fig. 3b, c)
Among the three genes that were confirmed to show a
change of hepatic mRNA levels, we focused on the Iah1
gene as a candidate gene for Fl1sa. We chose this gene
because the Iah1 mRNA level in the DNA microarray
showed the lowest P-value and the Iah1 protein was ex-
pected to have the esterase activity (Table 2).
Table 1 Body weight, body mass index, food intake, and body
composition of A/J and A/J-12SM strains fed the high-fat diet for
7 weeks
A/J (n = 9) A/J-12SM (n = 10) P-value
Initial body weight (g)a 21.6 ± 0.4 21.3 ± 0.4 NS
Final body weight (g)b 36.2 ± 1.0 34.4 ± 0.7 NS
Body mass index (g/cm2) 0.311 ± 0.006 0.301 ± 0.006 NS
Food intake (g/week) 20.3 ± 0.3 20.0 ± 0.3 NS
Weights of tissue (g/100 g bw)
Liver 4.00 ± 0.06 3.55 ± 0.08** 0.0003
Subcutaneous fatc 3.30 ± 0.19 3.21 ± 0.15 NS
Epididymal fat 5.21 ± 0.14 5.56 ± 0.24 NS
Retroperitoneal fat 1.45 ± 0.09 1.39 ± 0.09 NS
Mesenteric fat 2.75 ± 0.14 2.47 ± 0.12 NS
Blood glucose (mg/dl) 224.5 ± 5.5 192.7 ± 7.8** 0.0047
Serum insulin (ng/ml) 1.81 ± 0.23 1.08 ± 0.12* 0.0109
Each value is expressed as the mean ± SEM
*P < 0.05, **P < 0.01, significant difference from the value of A/J by
Student’s t-test
aInitial body weight was measured at 6 weeks of age (at 0 weeks of feeding
with the HFD)
bFinal body weight was measured at 13 weeks of age (at 7 weeks of feeding
with the HFD)
cSubcutaneous fat was defined as fat pads below the root of the forefoot on































Fig. 2 Serum lipids of A/J mice and A/J-12SM consomic mice at 7 weeks of feeding with the high-fat diet. a Serum TG, TC, HDL-C, and (b) serum
FFA levels of A/J and A/J-12SM mice at 7 weeks of feeding with the HFD (n = 8–10; *P < 0.05 versus A/J mice)
Kobayashi et al. BMC Genetics  (2016) 17:73 Page 3 of 10
Table 2 Genes differentially expressed between the livers of A/J mice and A/J-12SM mice on chromosome 12
Probe ID Gene symbol Description Position (bp) GenBank RefSeq P-value Fold
change
1454898_s_at Iah1 isoamyl acetate-hydrolyzing esterase
1 homolog (S. cerevisiae)
21316392–
21323605
AU016407 NM_026347 0.00020 4.803
1459274_at Gpr135 G protein-coupled receptor 135 72069618–
72070991
AV221890 NM_181752 0.00029 2.016
1429119_at Iah1 isoamyl acetate-hydrolyzing esterase
1 homolog (S. cerevisiae)
21316392–
21323605
AK005287 NM_026347 0.00059 2.899
1416951_a_at Atp6v1d ATPase, H+ transporting, V1 subunit D 78842989–
78861638
NM_023721 NM_023721 0.00157 0.492
1443933_at Tc2n tandem C2 domains, nuclear 101645443–
101718523
BB548141 NM_028924 0.00163 0.371





BB414446 NM_011739 0.00183 3.096




BB071632 NM_007951 0.00218 0.827
1439045_x_at Tc2n tandem C2 domains, nuclear 101645443–
101718523
AV376747 NM_028924 0.00245 0.038





1434437_x_at Rrm2 ribonucleotide reductase M2 24708241–
24714146
AV301324 NM_009104 0.00340 0.546
1446643_at 5330409N07Rik RIKEN cDNA 5330409 N07 gene 98444816–
98448333
BB022219 AK030416 0.00422 1.936
1418587_at Traf3 Tnf receptor-associated factor 3 111166370–
111267153
U21050 NM_011632 0.00423 0.861




BC016497 NM_026114 0.00473 4.125
1428810_at 2700097O09Rik RIKEN cDNA 2700097O09 gene 55045661–
55080110
AK012621 NM_028314 0.00573 1.337
1447623_s_at Prkd1 protein kinase D1 50341231–
50649223
AV297026 NM_008858 0.00660 0.413
1449110_at Rhob ras homolog gene family, member B 8497763–
8499985
BC018275 NM_007483 0.00676 1.746









BM123748 NM_001015099 0.00809 0.636




BG068268 NM_177806 0.00821 0.378
1447341_at Esyt2 extended synaptotagmin-like protein 2 116281222–
116373096
BE456208 NM_028731 0.00859 1.141




BB770958 NM_145836 0.00928 1.464





NM_011739 NM_011739 0.00944 1.573
1421430_at Rad51b RAD51 homolog B 79297351–
79508656
NM_009014 NM_009014 0.00982 2.596
1436438_s_at Dcaf5 DDB1 and CUL4 associated factor 5 80335847–
80436601
BM234499 NM_177267 0.00984 1.410
Bold genes exist in the chromosomal region of Fl1sa. The fold change was calculated by the gene expression level in A/J-12SM relative to that in A/J mice
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We compared the Iah1 mRNA level among tissues
(liver, kidney, epididymal fat, lung, spleen, and muscle)
by using the qPCR method (Fig. 3b). The Iah1 mRNA
levels in the liver, kidney, and lung were significantly
higher in A/J-12SM mice than in A/J mice. In contrast,
the Iah1 mRNA levels in epididymal fat, spleen, and
muscle were similar between A/J mice and A/J-12SM
mice. In both A/J mice and A/J-12SM mice, the Iah1
mRNA level in the kidney was the highest among the
tissues. The hepatic Iah1 protein level in A/J-12SM mice
was about 4.8-fold higher than that in A/J mice (Fig. 3c).
Lipid metabolism in Hepa1-6 cells stably overexpressing
mouse Iah1 (Fig. 4)
We transfected mouse Iah1 cDNA derived from SM/J
into Hepa1-6 cells and obtained Hepa1-6 cells stably
overexpressing the mouse Iah1 protein (Iah1-cells). The
mRNA level and protein level of Iah1 in the non-
transfected cells (control cells) could be detected by the
qPCR method and western blotting (Fig. 4a and b). The
protein level of Iah1 in the Iah1-overexpressed cells was
about 42-fold higher than that in the control cells
(Fig. 4b). To investigate the effect of stably overexpress-
ing mouse Iah1 protein on lipid metabolism in hepato-
cytes, we performed an analysis of the mRNA levels of
lipid metabolism-related genes (Fig. 4c). The mRNA
levels of Cd36 (fatty acid transporter) in the Iah1-cells
were significantly lower than those in the control cells.
The mRNA levels of Mtp1 (microsomal transfer protein
1) did not differ between the control and the Iah1-cells.
The genes Pparg2 (peroxisome proliferator-activated
receptor γ), Srebf1 (sterol regulatory element binding
protein 1), Gpam (glycerol-3-phosphate acyltransferase,
mitochondrial; Gpat, synonymous gene symbol), and
Dgat2 (acyl-CoA:diacylglycerol acyltransferase 2) regu-
late fatty acid and TG synthesis. The mRNA levels of
Srebf1 and Gpam were higher in the Iah1-overexpressed
cells compared to the control cells. In contrast, the
mRNA level of Dgat2 was significantly lower in the
Iah1-overexpressed cells than in the control cells. The
mRNA level of Atgl (adipose triglyceride lipase), which
codes the protein of hepatic major TG lipase, was not
changed. In the absence of oleic acid treatment (basal
condition), the cellular TG contents did not differ be-
tween the control cells and Iah1-cells (Fig. 4d). After
treatment with oleic acid, the cellular TG contents in
both cell lines were increased. However, overexpression
of Iah1did not change the cellular TG contents.
Discussion
We previously mapped a highly significant QTL for fatty
liver (Fl1sa) to mouse chromosome 12 in the SMXA-5
mouse, a mouse model for HFD-induced fatty liver and
type 2 diabetes. To confirm the effect of this QTL, we
constructed A/J-12SM consomic mice. Analysis of the A/
J-12SM consomic mice revealed that the SM/J allele on
chromosome 12 was resistant to fatty liver [4]. In this
study, to elucidate the genetic basis of Fl1sa, we first in-
vestigated fatty liver-related traits in A/J-12SM consomic
mice (Table 1, Figs. 1 and 2). The phenotypic analysis of
A/J-12SM mice showed that the SM/J segment of
chromosome 12 contributed to the lower values in liver
Fig. 3 Gene expression levels and protein levels of candidate genes for Fl1sa. a The hepatic mRNA levels of genes identified from a DNA
microarray by real-time RT-PCR analyses (n = 9–10; *P < 0.05, **P < 0.01 versus A/J mice). b The tissue distribution of Iah1 mRNA levels in A/J and
A/J-12SM mice at 7 weeks of feeding with the HFD (n = 4–5; *P < 0.05 versus A/J mice). c The hepatic levels of Iah1 protein in A/J and A/J-12SM
mice at 7 weeks of feeding with the HFD by Western blotting (n = 4; **P < 0.01 versus A/J mice)
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weight, liver lipids content, blood glucose concentration,
and serum insulin concentration. We previously mapped
the QTLs for glucose tolerance, non-fasting blood
glucose level, and serum insulin levels to the proximal
region of chromosome 12 [7]. On these QTLs of
chromosome 12, the A/J allele increased the values of
each phenotype. Therefore, the results for A/J-12SM con-
somic mice confirmed that chromosome 12 contained
not only genes involved in the regulation of liver lipid
metabolism, but also several genes regulating glucose
metabolism and insulin sensitivity. Significant differences
in the liver lipid contents between A/J mice and A/J-
12SM consomic mice appeared in the animals fed an
HFD for 11 weeks, but not in those on the ND (Fig. 1).
These results showed that the A/J-12SM consomic mice
were resistant to HFD-induced fatty liver, and demon-
strated that mouse chromosome 12 contained some of
the genes responsible for HFD-induced fatty liver. Next,
in order to identify these genes, we compared the
hepatic gene expression profile between A/J mice and
A/J-12SM consomic mice fed the HFD, by using a DNA
microarray analysis. We identified three candidate genes
(Iah1, Rrm2, Prkd1) which had significantly different levels
of expression between A/J mice and A/J-12SM consomic
mice within the chromosomal region of Fl1sa (centro-
mere-54.1 Mb). RRM2 is one of the subunits of the
ribonucleotide reductase holoenzyme. The ribonucleotide
reductase, which is a rate-limiting enzyme in the pro-
duction of 2’-deoxyribonucleoside 5’-triophosphates
(dNTPs), is required for DNA synthesis. In a human
study, expression of the Rrm2 gene was shown to be
increased in various types of cancer [8]. Protein kinase D1
(PKD1), which is coded by the Prkd1 gene, belongs to the
family of stress-activated serine/threonine kinases. PKD1
is activated by the signal via Gq-coupled receptors and
protein kinase C, and then phosphorylates various pro-
teins involved in cell growth, apoptosis, adhesion, and
angiogenesis [9]. Dysregulation of PKD1 leads to the de-
velopment of cancer and cardiac hypertrophy [10–12].
The mRNA levels of both Rrm2 and Prkd1 were higher in
A/J than in A/J-12SM mice (Fig. 3a), but occurrence of
liver cancer in A/J mice has not been reported. At present,
the relationship between these genes and lipid metabolism
remains uncertain.
Based on the results of the DNA microarray analysis,
we focused on the Iah1 gene (Table 2). A previous study
reported that mouse Iah1 mRNA was detected in the
rostral striatum, kidney, liver, and lung [13]. Fukuda et al.
reported that the yeast IAH1 protein has esterase activity
for acetate esters such as isoamyl acetate and isobutyl
acetate [6]. We found that the Iah1 gene was widely
expressed in mouse tissues (liver, kidney, epididymal fat,
Fig. 4 Overexpression of mouse Iah1 in Hepa1-6 cells. a The Iah1 mRNA level in non-transfected (control) and mouse Iah1 cDNA-transfected
(Iah1) cells. Iah1 cells were shown to stably overexpress mouse Iah1 protein. b The Iah1 protein level in control cells and mouse Iah1 cells. c The
mRNA levels of genes related to lipid metabolism (n = 4–5; *P < 0.05, **P < 0.01 versus A/J mice). d The cellular TG contents in non-transfected
(control) and mouse Iah1 cDNA-transfected (Iah1) cells. The treatment medium consisted of serum-free medium plus 0.333 mM oleic acid and
was administered to the treatment group for 48 h. The basal group was cultured in serum-free medium without oleic acid. The analyses were
performed in duplicate, and at least two independent experiments were performed. The data were analyzed by two-way ANOVA. Oleic acid
effect, P < 0.05; Iah1 effect, not significant; Oleic acid × Iah1 (interaction) effect, not significant
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lung, spleen, muscle) (Fig. 3b), and the mRNA levels in
the liver and kidney in A/J mice were especially low com-
pared to those in A/J-12SM mice. However, there has been
no report about the function of the mouse Iah1 protein.
We focused on the Iah1 mRNA level, because the hepatic
Iah1 mRNA level was markedly low in A/J mice (Fig. 3).
In this study, we constructed Hepa1-6 cells stably
overexpressing the mouse Iah1 protein and found that
overexpression of the Iah1 protein suppressed the expres-
sion levels of lipid metabolism-related genes such as Cd36
and Dgat2 (Fig. 4). Hepatic Cd36 mRNA expression in
C57BL/6 N mice was up-regulated by feeding with the
HFD (82 % of calories as fat) for 2 weeks [14]. Diet-
induced obesity caused an elevation of hepatic Cd36 ex-
pression, and this elevation was correlated with the in-
crease in liver TG storage. In vivo, adenoviral gene
delivery of Cd36 to the mouse liver has been shown to
lead to an increase in hepatic fatty acid uptake and TG
storage in the liver [15]. From our DNA microarray data,
the hepatic Cd36 mRNA level in A/J mice was about 2.6-
fold higher than that in A/J-12SM mice. In contrast, the
mRNA levels of the other genes (Srebf1, Gpam, and
Dgat2) regulated by Iah1 overexpression (Fig. 4c) were not
different between these two strains (<0.667-fold or >1.5-
fold). Our data implied that the elevation of the Cd36
mRNA level in liver was correlated with the increase of
hepatic TG accumulation. TG is synthesized via the
acylation of diacylglycerol by DGAT enzymes (Dgat1 and
Dgat2). Overexpression of the Dgat2 protein in mice has
been reported to increase hepatic TG synthesis [16].
Dgat2-knockout mice die soon after birth because of the
significant reduction in basal TG synthesis [17]. Dgat2
antisense oligo (ASO) treatment of HFD-induced obese
C57BL/6 J mice and ob/ob mice suppresses Dgat2 mRNAs
in the liver, resulting in a reduction in hepatic TG [18]. In
addition, Dgat2 ASO treatment in rats with diet-induced
hepatic steatosis was shown to reduce hepatic diacylglyc-
erol and TG contents, but Dgat1 ASO treatment did not
reduce either [19]. These reports indicate that the
reduction of the mRNA levels of Cd36 and Dgat2 in
liver contributes to the suppression of lipid accumu-
lation in the liver.
We speculate that the elevation of Iah1 gene ex-
pression suppresses the TG synthesis and the liver lipid
accumulation via the reduction of Cd36 and Dgat2 ex-
pression. However, the regulatory mechanisms of Cd36
and Ggat2 gene expressions by Iah1 are unknown. In S.
cerevisiae, the IAH1 protein exhibits esterase activity
against the ester bonds between alcohol and fatty acid
[5, 6]. Therefore, we also speculate that the substrates
and/or the metabolites that were catalyzed by the
mouse Iah1 protein might regulate the expressions of
genes related to lipid metabolism. Although the ester-
ase properties of the mouse Iah1 protein are not yet
known, we are currently trying to clarify the physio-
logical substrates of this protein.
Conclusions
This study demonstrated that Fl1sa, a QTL for fatty liver
on the proximal region of chromosome 12, was the locus
that was affected by feeding with the HFD, but not
affected by the ND. We also showed that mouse Iah1 is
a candidate gene for Fl1sa. Finally, we showed for the
first time that Iah1 regulated the expressions of the
Cd36 and Dgat2 genes, which play important roles in
TG synthesis and lipid metabolism. In future experi-
ments, to identify the gene responsible for Fl1sa, we will
construct several congenic strains. By using these con-
genic mice, we can finely map the chromosomal region
containing the responsible gene. Simultaneously, to de-
termine whether the Iah1 gene is responsible for Fl1sa,
we will construct Iah1-knockout mice, which will con-
tribute to the functional analysis of mouse Iah1. Based
on our present findings, Iah1 might prove to be a novel
mediator of lipid metabolism.
Methods
Animals
The A/J-Chr12SM consomic strain was produced at the
Institute for Laboratory Animal Research, Nagoya Uni-
versity School of Medicine. The A/J-12SM consomic
mouse strain was established by introduction of the
donor SM/J chromosome 12 into the recipient A/J back-
ground as previously described [20]. A/J male mice were
purchased from Japan SLC (Hamamatsu, Japan). In this
study, only male mice were used for the phenotypic ana-
lyses. Mice were maintained in a temperature-controlled
room (23 ± 2 °C) and 55 ± 5 % humidity with a 12-h
light/dark cycle and ad libitum access to food and water
under conventional conditions. Mice were weaned at
3 weeks of age in a cage containing five animals or
fewer. Until 6 weeks of age, all mice were fed a rodent
standard laboratory chow (CE2; Nihon CLEA, Japan).
Animal care and all experimental procedures were ap-
proved by the Animal Experiment Committee, Graduate
School of Bioagricultural Sciences, Nagoya University
(approval No. 2008031801, 2011030404, 2012022805),
and were conducted according to the Regulations on
Animal Experiments of Nagoya University.
Experimental schedule and diet composition
From 6 weeks of age, mice were switched from their
standard laboratory diets to the HFD (HFD group), or
continued to be fed their standard laboratory diets (ND
group). In the ND group, A/J mice and A/J-12SM mice
were kept at one animal per cage and fed the standard
laboratory chow for 11 weeks. After 11 weeks of feeding
with the ND, the mice were killed by decapitation, and
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the liver was collected at 13:00–14:00 h after 4-h diet
deprivation. In the HFD group, A/J mice and A/J-12SM
consomic mice were kept at one animal per cage and fed
the powdered HFD for 3, 7, or 11 weeks. The compos-
ition of the powdered HFD (weight %) was as follows:
casein, 20.9; carbohydrate (corn starch: sucrose, 1:1),
36.9; AIN93MX mineral mixture, 3.5; AIN93VX vitamin
mixture, 1.0; choline chloride, 0.2; corn oil, 3.5; lard,
30.0; and cellulose (AVICEL type FD-101; Asahi Chem-
ical Industry, Osaka, Japan), 4.0. The content of fat in
this HFD was 33.5 % (weight %). After 3, 7, or 11 weeks
on the HFD, mice were killed by decapitation, and the
serum, liver, and fat pads were collected at 13:00–
14:00 h after 4-h diet deprivation. After 7 weeks on the
HFD, the measurement of BMI was performed as in our
previous report [21]. BMI was calculated as body weight
(g) divided by the square of the anal-nasal length (cm).
Hepatic lipid analysis
Frozen livers were homogenized with chloroform:metha-
nol (2:1), and the liver lipids were extracted into organic
solvents. A portion of this extract was dried, and the
hepatic contents of TG and TC were measured by the
triglyceride E-test (Wako, Tokyo, Japan) and the choles-
terol E-test (Wako), respectively. This extract was also
used to measure total liver lipids according to the
method of Folch et al. [22].
Serum glucose, insulin, and lipids
The serum glucose concentration was measured by a glu-
cose oxidase method (Glucose-B test Kit; WAKO, Tokyo,
Japan). Serum insulin, TG, TC, HDL-C, and non-esterified
free fatty acid concentrations were measured at the end of
the experiment (after 7 weeks of feeding with the HFD) by
using a Mouse Insulin ELISA kit (Morinaga Institute of
Biological Sciences Inc., Japan), Triglyceride-E kit (WAKO
Pure Chemical Industries, Japan), Cholesterol-E kit
(WAKO Pure Chemical Industries), HDL-Cholesterol-E
kit (WAKO Pure Chemical Industries), and NEFA C-kit
(WAKO Pure Chemical Industries), respectively.
Microarray experiments
Liver samples were collected from A/J male mice and
A/J-12SM male mice fed the HFD for 7 weeks. Total
RNA was isolated from the liver using TRI reagent
(Molecular Research Center Inc.) and cleaned using an
RNeasy Mini kit (Qiagen). We extracted the total RNA
from nine mice per strain. Extracted total RNA quality
was assessed with an Agilent Bioanalyzer (Agilent Tech-
nologies). cDNA synthesis and cRNA labeling reactions
were performed with a One-Cycle cDNA Synthesis Kit
and IVT Labeling Kit (Affymetrix). In order to minimize
the experimental variation, we used three arrays for each
strain and obtained data from three replicates. Each
biotinylated cRNA was prepared from the pooled RNA
samples of three mice. The biotinylated cRNAs were
hybridized with a probe array (Mouse Genome 430 2.0
Array) by using a Hybridization, Wash and Stain kit
(Affymetrix). Scanning was performed using a Scanner
3000 with GeneChip Operating Software (GCOS) (Affyme-
trix). Raw data were normalized with the MAS5.0 algo-
rithm by using Expression Console Software (Affymetrix).
The microarray data have been deposited in the NCBI
Gene Expression Omnibus (GEO) (GSE67340). Data were
analyzed by using GeneSpring GX7.3 software (Agilent
Technologies).
Real-time RT-PCR
Total RNA was extracted from liver and Hepa1-6 cells
using TRI reagent. To eliminate DNA contamination,
the RNA was treated with DNase (TURBO DNA-free;
Life Technologies). Subsequently, the cDNA was synthe-
sized by using a High Capacity Reverse Transcription kit
(Life Technologies). Gene expression was quantified by
real-time PCR using an ABI 7300 real-time PCR System
with Thunderbird qPCR Mix or Thunderbird SYBR
qPCR Mix (Toyobo, Tokyo, Japan). TaqMan primers
and probes were used to determine the mRNA levels
of mouse Iah1 (TaqMan Gene Expression Assays,
Mm00509467_m1; Applied Biosystems) and 18S rRNA
(Pre-developed TaqMan Assay Reagents, Eukaryotic 18S
rRNA 4319413E; Applied Biosystems). The primers used
for the SYBR Green assay are shown in Additional file 1.
The level of each mRNA was normalized to that of the
corresponding 18S rRNA.
Western blotting
The tissues and cells were homogenized in lysis buffer
(10 mM Tris (pH 7.4), 150 mM NaCl, 1 % Nonidet P-40,
0.5 % sodium deoxycholate, 0.1 % SDS) containing pro-
tease inhibitor cocktail (Complete Mini, Roche Applied
Science) with a homogenizer (HG-30; Hitachi). The
homogenates were centrifuged at 10,000 × g for 5 min
and the supernatant was obtained as protein extracts.
An aliquot of protein (4 μg) was subjected to SDS-PAGE
on 10 % acrylamide gel, and the proteins in the gel were
transferred onto PVDF membranes (Hybond P; GE
Healthcare). The membranes were incubated for 30 min
at room temperature with Blocking One (Nacalai Tesque)
and incubated overnight at 4 °C with the first antibody,
rabbit polyclonal anti-mouse Iah1 (1:20,000) and anti-β-
actin (1:10,000; #4967; Cell Signaling Technology Inc.),
then washed with TBS buffer containing 0.1 % Tween 20.
The membranes were incubated with the horseradish
peroxidase-conjugated goat anti-rabbit IgG antibody
(1:20,000 or 1:10,000; #7074; Santa Cruz Biotechnology,
USA) for 1 h at room temperature and washed. Each anti-
body was diluted with Can Get Signal (Toyobo). The
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membranes were autographed with a West Dura Western
Blot Detection kit using the ECL method (Thermo Fisher
Scientific). Each protein on the band was quantified with
Image J software.
Hepa1-6 cell culture and overexpression of mouse Iah1
Hepa1-6 cells, a mouse hepatocyte cell line (RBRC-
RCB1638 RIKEN BRC Cell Bank), were grown in high-
glucose Dulbecco’s modified Eagle’s medium (DMEM;
Wako Pure Chemical) supplemented with 10 % fetal bo-
vine serum (FBS), 100 U/ml penicillin, and 100 μg/ml
streptomycin at 37 °C in a 5 % CO2-humidified incubator.
Iah1 cDNA of SM/J mice was amplified with the
KOD-plus (TOYOBO) using the following primers: an
upper primer containing the start codon, CTTTCTAC-
CATGTCGCTGTGC; a lower primer containing the
stop codon, CTAATAGTCTCCATCTCCCAGCAG. The
cDNA fragment was subcloned into pcDNA3.3 TOPO
plasmid (Thermo Fisher Scientific). The Iah1-expressing
plasmid vector with CMV promoter contained Iah1
cDNA (759 bp) constructed from SM/J mice. To con-
struct the mouse Iah1-expressing stable cell line, Hepa1-
6 cells were seeded on 12-well plates (3 × 105 cells per
well) on day 0. After 24 h, the Iah1-expressing plasmid
vector (1.4 μg) was transfected using Lipofectamine
2000 reagent (Invitrogen). After 28 h of transfection, the
transfected cells were subcultured on a 60 mm dish
(6000 cells per dish) and incubated for 1 week. For the
selection of neomycin-resistant cells, cells were main-
tained in medium containing 500 μg/ml G418 disulfate
salt (Sigma Aldrich). Three weeks after colony selection
with G418, we obtained the Iah1 cDNA-expressing
stable cell line.
To assay the effect of overexpression of Iah1 on vari-
ous mRNA levels, cells were plated on 12-well plates
(2 × 105 cells per well) on day 0. After 72 h, the cells
were harvested and used for the assay of protein or the
extraction of total RNA.
To examine the effect of overexpression of Iah1 on the
intracellular accumulation of triglycerides, cells were
seeded on 12-well plates (2.5 × 105 cells per well) at day
0. At day 1, the culture medium was replaced with
serum-free medium containing 0.333 mM oleic acid
(oleic acid-BSA conjugated solution, finally containing
1 % BSA, (Sigma)) or serum-free medium alone. The
treatment medium without oleic acid-BSA was supple-
mented with 1 % BSA. After 2 days, the cells were homog-
enized in lysis buffer (50 mM Tris–HCl pH 7.4, 150 mM
NaCl, 2 mM EDTA, 1 % Triton X-100, and 0.5 % cholate).
The supernatants were obtained by centrifugation at
9730 × g for 10 min at 4 °C. Their triglycerides and protein
concentration were measured by a Triglyceride-E test and
a DC protein assay (Bio-Rad Laboratories, Japan),
respectively. The triglycerides content in cells was normal-
ized to that of protein content.
Statistical analysis
The results are expressed as the means with their standard
errors. Mean values, except for the data in Fig. 4d, were
compared using Student’s t-test when the variances of each
group were equal. When the variances of each group were
unequal, the significance of differences was determined
using Welch’s test. The data from Fig. 4d were analyzed by
two-way ANOVA. Differences with P < 0.05 were regarded
as significant. General statistical analyses were also per-
formed using StatView version 5.0 software (SAS Institute).
Additional file
Additional file 1: The primers for SYBR Green assay in real-time PCR.
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